Benzinga's Top Downgrades

by Lisa Levin, Benzinga Editor

August 14, 2014 9:23 AM | 1 min read | Make a Comment

Analysts at Topeka Capital downgraded The Madison Square Garden Company

MSG

from Buy to Hold. The target price for Madison Square Garden Company has been lowered from $67.00 to $63.00. Madison Square Garden Company's shares closed at $61.20 yesterday. Analysts at Wells Fargo downgraded SeaWorld Entertainment

SEAS

from Outperform to Market Perform. SeaWorld Entertainment's shares closed at $18.90 yesterday. Baird downgraded Theravance Biopharma

TBPH

from Neutral to Underperform. The target price for Theravance Biopharma is set to $21. Theravance Biopharma's shares closed at $29.65 yesterday. Goldman Sachs downgraded InterMune

ITMN

from Buy to Neutral. InterMune's shares closed at $52.06 yesterday.

Market News and Data brought to you by Benzinga APIs